However, other studies indicate variable pathology, including typical Lewy bodies, tau pathology, or nigral degeneration without Lewy bodies, suggesting LRRK2 mutations may predict specific PD sequelae [59,62-64]. This evidence concerns the gene MAPT and Parkinson disease.